Merck (MIL:1MRKX) FFO


MIL:1MRKX Merck & Co Inc MIL:1MRKX
60 GF Score
Price €108.38
GF Value €104.17
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Merck FFO?

FFO (Funds from operations) only applies to REITs.

MIL:1MRKX
60GF Score
Merck & Co Inc MIL:1MRKX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck (MIL:1MRKX) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of €108.38 is trading 4% above its estimated GF Value™ of €104.17. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for MIL:1MRKX:

  • FFO:
  • GF Value™: €104.17 vs. price of €108.38 (4% above fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the MIL:1MRKX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
60GF Score

Get the complete analysis for MIL:1MRKX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€108.38
Price
€104.17
GF Value